Virios Therapeutics (VIRI) Tops Q4 EPS by 4c

Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel
• Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance